IQVIA Holdings Inc Asset Resilience Ratio

Latest as of June 2026: 0.57%

IQVIA Holdings Inc asset resilience ratio. IQVIA Holdings Inc (IQV) has an Asset Resilience Ratio of 0.57% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See IQVIA Holdings Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$171.00 Million
Cash + Short-term Investments

Total Assets

$29.88 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of IQVIA Holdings Inc (2011–2025)

Asset resilience ratio of IQVIA Holdings Inc from 2011 to 2025. This chart shows how IQVIA Holdings Inc's Asset Resilience Ratio has changed over time. Read IQVIA Holdings Inc (IQV) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down IQVIA Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see IQV current and non-current assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $171.00 Million 0.57%
Total Liquid Assets $171.00 Million 0.57%

Asset Resilience Insights

  • Limited Liquidity: IQVIA Holdings Inc maintains only 0.57% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

IQVIA Holdings Inc Industry Peers by Asset Resilience Ratio

Compare IQVIA Holdings Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Revvity Inc.
NYSE:RVTY
Diagnostics & Research 0.00%
Wuhan Thalys Med Tech Co Ltd
SHG:603716
Diagnostics & Research 0.16%
JOONGANG DNM Co.Ltd
KQ:051980
Diagnostics & Research 27.26%
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193
Diagnostics & Research 70.50%
Krsnaa Diagnostics Limited
NSE:KRSNAA
Diagnostics & Research 9.90%
Sonic Healthcare Ltd
AU:SHL
Diagnostics & Research 0.13%
Integral Diagnostics Ltd
AU:IDX
Diagnostics & Research 0.03%
Australian Clinical Labs Ltd
AU:ACL
Diagnostics & Research 4.11%

IQVIA Holdings Inc Asset Resilience Ratio by Year (2011–2025)

IQVIA Holdings Inc asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for IQVIA Holdings Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 7.15% $2.14 Billion $29.94 Billion +0.30pp
2024-12-31 6.85% $1.84 Billion $26.90 Billion +1.24pp
2023-12-31 5.61% $1.50 Billion $26.68 Billion +0.44pp
2022-12-31 5.17% $1.31 Billion $25.34 Billion -0.82pp
2021-12-31 5.98% $1.48 Billion $24.69 Billion -1.76pp
2020-12-31 7.74% $1.90 Billion $24.56 Billion +3.88pp
2019-12-31 3.87% $899.00 Million $23.25 Billion -0.29pp
2018-12-31 4.16% $938.00 Million $22.55 Billion -0.26pp
2017-12-31 4.42% $1.00 Billion $22.74 Billion -1.42pp
2016-12-31 5.84% $1.24 Billion $21.21 Billion +6.68pp
2015-12-31 -0.84% $-32.91 Million $3.93 Billion +0.21pp
2014-12-31 -1.04% $-34.50 Million $3.31 Billion +0.27pp
2013-12-31 -1.32% $-40.35 Million $3.07 Billion +0.12pp
2012-12-31 -1.44% $-35.95 Million $2.50 Billion -0.49pp
2011-12-31 -0.95% $-22.11 Million $2.32 Billion --
pp = percentage points

About IQVIA Holdings Inc

NYSE:IQV USA Diagnostics & Research
Market Cap
$44.74 Billion
Market Cap Rank
#674 Global
#320 in USA
Share Price
$271.83
Change (1 day)
+2.62%
52-Week Range
$156.66 - $279.36
All Time High
$282.61
About

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment of… Read more